Congenital Hyperinsulinism: the Possibilities of Modern Diagnosis and Treatment
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 3, Issue 67
Abstract
Congenital hyperinsulinism (CHI) — one of the main causes underlying the development of persistent hypoglycemic conditions in childhood. The article presents the experience of diagnosis and treatment in patients with CHI. We have examined 7 children diagnosed with СHI aged 1 month to 1.5 years. For diagnosing CHI, we have used routine clinical and laboratory investigations, as well as molecular genetic and instrumental diagnostics (18F-DOPA positron emission tomography). Molecular genetic testing confirmed the diagnosis of CHI in 6 children. All 7 children with CHI had various resistance to conservative treatment, had a different degree of psychomotor development and seizures. Of them, 6 children underwent surgery with achievement of normoglycemia. Genetic testing and 18F-DOPA positron emission tomography should be carried out in all children with hypoglycemia and increased or normal levels of C-peptide and insulin to clarify the type of CHI. Further development of genetic diagnostics is necessary to find new CHI genes. Surgical treatment may be a treatment of choice in children with CHI, particularly in its focal form.
Authors and Affiliations
Ye. V. Hloba
Keywords
Related Articles
- EP ID EP222649
- DOI -
- Views 55
- Downloads 0
Clinical and Hormonal Characteristics of Patients with Giant Masses of Sellar-Chiasmatic Region
Objective: to study the clinical and hormonal characteristics of patients with giant masses of sellar-chiasmatic area. Material and methods. During the period from 2015 to 2016, we have examined 35 adult patients with pi...
State of antioxidant, pro-oxidant and endothelial systems in patients with chronic critical lower limb ischemia and high risk of reperfusion-reoxygenation complications
Background. Obliterating atherosclerosis of the peripheral arterial vessels accounts for more than 20 % of cases of cardiovascular pathology, that is more than in 3 % of the total population. Despite the large experience...
New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus
This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin del...
Activation of intracellular enzyme systems under the influence of pathogenetic factors of oncogenesis in patients with type 2 diabetes mellitus
Background. It is proved that patients with diabetes mellitus (DM) have an increased risk of cancer. The main factors of oncogenesis in DM are obesity, cytokine imbalance, hyperinsulinemia (HI), hyperglycemia. These diso...
Approaches to the correction of indexes of blood lipids and liver functional state in patients with hypothalamic dysfunction
The lecture presents a modern view on etiology, pathogenesis and correction of hypothalamic dysfunction, describes the correlation between hypothalamic dysfunction and liver functional state. The comprehensive method of...